BioCentury
ARTICLE | Regulation

Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science

Former senior agency officials say Hahn prioritized politics in authorizing COVID-19 convalescent plasma

August 24, 2020 2:04 AM UTC
Updated on Aug 29, 2020 at 3:25 AM UTC

FDA Commissioner Stephen Hahn’s decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19 have put politics ahead of science, former senior FDA officials told BioCentury.

“At this moment in time, the FDA can no longer call itself an independent and science-based regulatory agency,” Luciana Borio, former acting FDA chief scientist, told BioCentury. ...



Access The Full Article